{"id":"CHEMBL1075790","canonicalSmiles":"CO[C@@H]1[C@@H](O)[C@H](C)O[C@@H](O[C@H]2CC[C@]3(C=O)[C@H]4CC[C@]5(C)[C@@H](C6=CC(=O)OC6)CC[C@]5(O)[C@@H]4CC[C@@H]3C2)[C@H]1O","inchiKey":"PMTSPAGBAFCORP-HBUONDEYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PERUVOSIDE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Cannogenin .alpha.-l-thevetoside","Cannogenin thevetoside","Encordin","Peruvosid","Peruvoside"],"crossReferences":{"Wikipedia":["Peruvoside"],"drugbank":["DB13756"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL1089641","canonicalSmiles":"Cc1cc(-c2ccc(/N=N/c3c(S(=O)(=O)O)cc4cc(S(=O)(=O)O)cc(N)c4c3O)c(C)c2)ccc1/N=N/c1c(S(=O)(=O)O)cc2cc(S(=O)(=O)O)cc(N)c2c1O","inchiKey":"ZBNARPCCDMHDDV-HVMBLDELSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TRYPAN BLUE","yearOfFirstApproval":2004,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Trypan blue"],"crossReferences":{"DailyMed":["trypan%20blue"],"PubChem":["50112808"],"drugbank":["DB09158"],"chEBI":["78900"]},"childChemblIds":["CHEMBL1640"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 2004."}
{"id":"CHEMBL1090089","canonicalSmiles":"Cn1c(=O)c(Oc2ccc(F)cc2F)cc2cnc(NC(CCO)CCO)nc21","inchiKey":"JYYLVUFNAHSSFE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PAMAPIMOD","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Pamapimod","R-1503","R1503","RO 4402257","Ro-4402257"],"crossReferences":{"chEBI":["90685"]},"description":"Small molecule drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL1160567","canonicalSmiles":"N[C@@H](CCCNC(=O)CP(=O)(O)O)C(=O)O","inchiKey":"FCIHAQFHXJOLIF-YFKPBYRVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1160567","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02011"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1161222","canonicalSmiles":"O=P(O)(O)C(F)(F)c1ccc(CCCCc2ccc(C(F)(F)P(=O)(O)O)cc2)cc1","inchiKey":"SRHSAABKYJDBDV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1161222","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB04204"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1162488","canonicalSmiles":"O=C(O)C(=O)Cc1ccccc1","inchiKey":"BTNMPGBKDVTSJY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PHENYLPYRUVATE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Phenylpyruvate"],"crossReferences":{"PubChem":["144211679"],"drugbank":["DB03884"],"chEBI":["30851"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1163070","canonicalSmiles":"Nc1ncnc2c1ncn2[C@@H]1O[C@H](COS(=O)(=O)NC(=O)[C@@H](N)CO)[C@@H](O)[C@H]1O","inchiKey":"HQXFJGONGJPTLZ-YTMOPEAISA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"Sersa","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Sersa"],"crossReferences":{"drugbank":["DB03869"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1168","canonicalSmiles":"CCOC(=O)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N1[C@H](C(=O)O)C[C@@H]2CCC[C@@H]21","inchiKey":"HDACQVRGBOVJII-JBDAPHQKSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"RAMIPRIL","yearOfFirstApproval":1991,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Altace","Lopace","Ramipril","Ranace","Tritace"],"synonyms":["C09AA05","Cardace","Corpril","Delix","Ecator","HOE 498","HOE-498","Hopace","NSC-758933","Pramace","Ramace","Ramipres","Ramipril","Triatec","Unipril","Vesdil"],"crossReferences":{"DailyMed":["ramipril"],"PubChem":["144204259","170464731","49664947"],"Wikipedia":["Ramipril"],"drugbank":["DB00178"],"chEBI":["8774"]},"linkedTargets":{"rows":["ENSG00000159640"],"count":1},"linkedDiseases":{"rows":["EFO_0003086","EFO_0003777","Orphanet_98895","EFO_0000275","EFO_0000401","EFO_0004997","EFO_0000373","MONDO_0002462","EFO_1001461","EFO_0003913","MONDO_0001302","EFO_0003914","EFO_0003911","EFO_0002690","EFO_1001375","EFO_0003144","EFO_0000712","EFO_0003884","EFO_0004285","EFO_0000400","EFO_0002546","EFO_0000685","HP_0003124","EFO_0001645","EFO_0000319","EFO_0004194","EFO_0000537","Orphanet_98896","EFO_0000195","EFO_0000589","MONDO_0001134","MONDO_0100096","MONDO_0005147","EFO_0008583","EFO_0000612","MONDO_0005148","EFO_0004265"],"count":37},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1991 and has 9 approved and 19 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL11722","canonicalSmiles":"N[C@@H](CCO)C(=O)O","inchiKey":"UKAUYVFTDYCKQA-VKHMYHEASA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"HOMOSERINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Isothreonine","L-Homoserine"],"crossReferences":{"Wikipedia":["Homoserine"],"drugbank":["DB04193"],"chEBI":["15699"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1182833","canonicalSmiles":"COc1cc2c(cc1OC)[C@@H](Cc1cc(OC)c(OC)c(OC)c1)[N+](C)(CCCOC(=O)CC/C=C/CCC(=O)OCCC[N+]1(C)CCc3cc(OC)c(OC)cc3[C@H]1Cc1cc(OC)c(OC)c(OC)c1)CC2","inchiKey":"ILVYCEVXHALBSC-OTBYEXOQSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MIVACURIUM","yearOfFirstApproval":1992,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["BW B109OU","BW-B109OU","Mivacurium","Mivacurium cation","Mivacurium ion"],"crossReferences":{"PubChem":["144206462","50112723"],"drugbank":["DB01226"],"chEBI":["6958"]},"childChemblIds":["CHEMBL984"],"linkedTargets":{"rows":["ENSG00000170175","ENSG00000138435","ENSG00000135902","ENSG00000108556","ENSG00000196811"],"count":5},"linkedDiseases":{"rows":["HP_0001410"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1992 and has 1 investigational indication."}
{"id":"CHEMBL1200376","canonicalSmiles":"C[C@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(OC(=O)c1ccccc1)C(=O)CO","inchiKey":"SOQJPQZCPBDOMF-YCUXZELOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BETAMETHASONE BENZOATE","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Uticort"],"synonyms":["Betamethasone 17-benzoate","Betamethasone benzoate","W 5975","W-5975"],"linkedTargets":{"rows":["ENSG00000113580"],"count":1},"linkedDiseases":{"rows":["HP_0006536","EFO_0009552","HP_0001742","HP_0004798","EFO_0005752"],"count":5},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1982 and has 4 approved indications."}
{"id":"CHEMBL1200569","canonicalSmiles":"Cn1c(=O)c2c(ncn2C)n(C)c1=O.O=C(O)CC(O)(CC(=O)O)C(=O)O","inchiKey":"RCQXSQPPHJPGOF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CAFFEINE, CITRATED","yearOfFirstApproval":1999,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL113","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Cafcit","Caffeine citrate","Peyona"],"synonyms":["Caffeine citrate","Caffeine mixture with citric acid","Caffeine, citrated","Citrated caffeine"],"crossReferences":{"DailyMed":["caffeine%20citrate"],"PubChem":["144203650","170464929"]},"linkedTargets":{"rows":["ENSG00000282608","ENSG00000170425","ENSG00000128271","ENSG00000163485"],"count":4},"linkedDiseases":{"rows":["EFO_0001421","MONDO_0004567","HP_0001298","EFO_0003917","HP_0002104","EFO_0003843","EFO_1001158"],"count":7},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1999 and has 6 investigational indications."}
{"id":"CHEMBL1200582","canonicalSmiles":"Cl.NCC(=O)CCC(=O)O","inchiKey":"ZLHFONARZHCSET-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AMINOLEVULINIC ACID HYDROCHLORIDE","yearOfFirstApproval":1999,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL601","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Ameluz","Gleolan","Levulan"],"synonyms":[".delta.-aminolevulinic acid hydrochloride","5 ala hcl (trivial name)","Alabel","Alaglio","Aminolevulinic acid hcl","Aminolevulinic acid hydrochloride","Gliolan","NPC-07","NSC-18509"],"crossReferences":{"DailyMed":["aminolevulinic%20acid%20hydrochloride"],"PubChem":["144204979","170464700","26748927"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1999 and has 15 investigational indications."}
{"id":"CHEMBL1200612","canonicalSmiles":"CCCCOc1cc(C(=O)NCCN(CC)CC)c2ccccc2n1.Cl","inchiKey":"IVHBBMHQKZBJEU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DIBUCAINE HYDROCHLORIDE","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1086","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Heavy solution nupercaine","Nupercainal","Nupercaine"],"synonyms":["Cincaine chloride","Cinchocaine hydrochloride","Dibucaine hcl","Dibucaine hydrochloride","NSC-756724"],"crossReferences":{"PubChem":["26747981","26747982","50107328","56422129","855998"],"chEBI":["59735"]},"linkedTargets":{"rows":["ENSG00000185313","ENSG00000183873"],"count":2},"linkedDiseases":{"rows":["EFO_0003958","EFO_0009552"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1982 and is indicated for hemorrhoid and sunburn."}
{"id":"CHEMBL1200757","canonicalSmiles":"CC(=O)O[C@H]1C[C@@H]2CC[C@@H]3[C@H](CC[C@@]4(C)[C@H]3C[C@H]([N+]3(C)CCCCC3)[C@@H]4OC(C)=O)[C@@]2(C)C[C@@H]1[N+]1(C)CCCCC1.[Br-].[Br-]","inchiKey":"NPIJXCQZLFKBMV-YTGGZNJNSA-L","drugType":"Small molecule","blackBoxWarning":false,"name":"PANCURONIUM BROMIDE","yearOfFirstApproval":1972,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL185073","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Mioblock","Pancuronium bromide","Pavulon"],"synonyms":["Bromurex","Mioblock","NSC-293162","ORG NA 97","ORG-NA 97","ORG-NA-97","Pancuronium bromide"],"crossReferences":{"DailyMed":["pancuronium%20bromide"],"PubChem":["144205586","50106734"],"chEBI":["7908"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1972."}
{"id":"CHEMBL1200944","canonicalSmiles":"CC1(C)[C@H](C(=O)[O-])N2C(=O)C[C@H]2S1(=O)=O.[Na+]","inchiKey":"NKZMPZCWBSWAOX-IBTYICNHSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"SULBACTAM SODIUM","yearOfFirstApproval":1986,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL403","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["CP-45,899-2","CP-45899-2","Sulbactam (as sodium)","Sulbactam sodium","Sulbactam sodium salt"],"crossReferences":{"DailyMed":["sulbactam%20sodium"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1986 and is indicated for infection and has 1 investigational indication."}
{"id":"CHEMBL1201453","drugType":"Protein","blackBoxWarning":false,"name":"ALBUMIN, IODINATED I 131 SERUM","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Albumotope 1-131","Ihsa 1-131","Megatope","Risa-131"],"synonyms":["Albumin iodinated i-131 serum","Albumin, iodinated (131i) human serum","Albumin, iodinated (131i) human serum, injection","Albumin, iodinated i 131 serum","Albumin, iodinated i-131 serum","Albumin,iodinated i-131 serum","Albumin,iodinated serum,i-131","Human albumin i-131","Human serum albumin i-131","Iodinated (131i) human serum albumin","Iodinated (131i) human serum albumin injection","Iodinated i 131 serum albumin","Iodinated i-131 serum albumin","Iodine (131i) human albumin"],"crossReferences":{"DailyMed":["albumin%20iodinated%20i-131%20serum"]},"description":"Protein drug with a maximum clinical trial phase of IV."}
{"id":"CHEMBL1201506","drugType":"Antibody","blackBoxWarning":true,"name":"GEMTUZUMAB OZOGAMICIN","yearOfFirstApproval":2000,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["United States"],"year":2010},"tradeNames":["Mylotarg"],"synonyms":["CDP-771","CMA-676","CMC-676","Gemtuzumab ozogamicin","L01XC05","WAY-CMA-676"],"crossReferences":{"DailyMed":["gemtuzumab%20ozogamicin"],"DrugCentral":["4980"],"Wikipedia":["Gemtuzumab_ozogamicin"]},"linkedTargets":{"rows":["ENSG00000105383"],"count":1},"linkedDiseases":{"rows":["EFO_0000565","EFO_0000198","EFO_0000616","EFO_0000095","EFO_0000220","MONDO_0019457","EFO_0000222","EFO_1000309","EFO_0000224","MONDO_0004643"],"count":10},"description":"Antibody drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2000 and is indicated for neoplasm and myeloid leukemia and has 7 investigational indications. It was withdrawn in United States  in 2010. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1201734","canonicalSmiles":"Cl.Cn1c(CCCC(=O)O)nc2cc(N(CCCl)CCCl)ccc21","inchiKey":"ZHSKUOZOLHMKEA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BENDAMUSTINE HYDROCHLORIDE","yearOfFirstApproval":2008,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL487253","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Belrapzo","Bendamustine hydrochloride","Bendeka","Ribomustine","Treanda"],"synonyms":["Bendamustine hcl","Bendamustine hydrochloride","NSC-138783","Ribomustin","SDX-105","SYB L-0501","SYBL-0501"],"crossReferences":{"DailyMed":["bendamustine%20hydrochloride"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2008 and has 3 approved and 15 investigational indications."}
{"id":"CHEMBL1213327","canonicalSmiles":"CC(C)(COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1OP(=O)(O)O)[C@@H](O)C(=O)NCCC(=O)NCCS","inchiKey":"RGJOEKWQDUBAIZ-IBOSZNHHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"COENZYME_A","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CoASH","Coenzyme A","Coenzyme_a"],"crossReferences":{"Wikipedia":["Coenzyme_A"],"drugbank":["DB01992"],"chEBI":["15346"]},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL1215","canonicalSmiles":"CNC[C@H](O)c1cccc(O)c1","inchiKey":"SONNWYBIRXJNDC-VIFPVBQESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PHENYLEPHRINE","yearOfFirstApproval":1952,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["(-)-phenylephrine","(r)-phenylephrine","AB-101 (PHENYLEPHRINE)","Cyclomydril","Duo-Medihaler","J8.601K","M-oxedrine","M-sympathol","M-sympatol","M-synephrine","Meta-synephrine","Metasynephrine","Phenylephrine","Phenylephrine minims","Phenylephrine, (r)-","R(-)-mezaton"],"crossReferences":{"DailyMed":["phenylephrine%20hydrochloride"],"PubChem":["11111644","90340906"],"Wikipedia":["Phenylephrine"],"drugbank":["DB00388"],"chEBI":["8093"]},"childChemblIds":["CHEMBL2062264","CHEMBL1200339"],"linkedTargets":{"rows":["ENSG00000171873","ENSG00000170214","ENSG00000120907"],"count":3},"linkedDiseases":{"rows":["EFO_0004610","HP_0000989","EFO_0007486","EFO_0006834","HP_0012735","EFO_0005252","EFO_0007533","MONDO_0005271","MONDO_0024355","HP_0011950","EFO_0002950","EFO_0600064","EFO_0003966","HP_0100543","EFO_0000178","EFO_0000544","EFO_0005758","EFO_0003144","EFO_1000645","EFO_1001898","MONDO_0005129","EFO_0000712","EFO_0009552","EFO_0005751","HP_0011499","EFO_0000616","EFO_0008521","HP_0002140","EFO_0004269","HP_0001919","EFO_0001358","EFO_0000319","HP_0001742","EFO_0003843","EFO_0001073","EFO_0007214","EFO_0000537","MONDO_0005301","EFO_0009688","HP_0000138","Orphanet_230","EFO_0007328","EFO_0009523","HP_0031273","EFO_0003833","EFO_1001158","EFO_0000668","EFO_0004264","EFO_0003956","EFO_0005251"],"count":50},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1952 and has 11 approved and 32 investigational indications."}
{"id":"CHEMBL1231399","canonicalSmiles":"O=C1CC(=O)N([C@@H]2O[C@H](COP(=O)(O)O)[C@@H](O)[C@H]2O)C(=O)N1","inchiKey":"AODYJUNLDJOADV-YXZULKJRSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1231399","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03668"],"chEBI":["41150"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1233300","canonicalSmiles":"O=S(=O)(c1cccc2c(O)nccc12)N1CCCNCC1","inchiKey":"ZAVGJDAFCZAWSZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"HYDROXYFASUDIL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Hydroxy-Fasudil"],"crossReferences":{"drugbank":["DB04707"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1234151","canonicalSmiles":"CC(C)C[C@H](NC(=O)[C@@H](Cc1cccc2ccccc12)NC(=O)N1CCOCC1)B(O)O","inchiKey":"MQMHIOPMTAJOHV-RTWAWAEBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1234151","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["518751"],"drugbank":["DB04732"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1236882","canonicalSmiles":"CN1CCC(C#N)(NC(=O)[C@H](CC2CCCCC2)NC(=O)N2CCOCC2)CC1","inchiKey":"IRSOCWQJNYLTDD-SFHVURJKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1236882","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08752"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1256575","canonicalSmiles":"CCCCS(=N)(=O)CCC(N)C(=O)O","inchiKey":"KJQFBVYMGADDTQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1256575","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["26747459","50105970","85230938"],"drugbank":["DB12870"],"chEBI":["28714"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1275","canonicalSmiles":"CCCN1C[C@H](CSC)C[C@@H]2c3cccc4[nH]cc(c34)C[C@H]21.CS(=O)(=O)O","inchiKey":"UWCVGPLTGZWHGS-ZORIOUSZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PERGOLIDE MESYLATE","yearOfFirstApproval":1988,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL531","hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["United States"],"classes":["Cardiotoxicity"],"year":2007},"tradeNames":["Celance","Pergolide mesylate","Permax"],"synonyms":["LY 127809","LY-127809","NSC-319773","NSC-758442","Pergolide mesilate","Pergolide mesylate","Pergolide methanesulfonate"],"crossReferences":{"PubChem":["11533039","144204371","170465250","50106872","56422469"],"chEBI":["8021"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1988. It was withdrawn in United States  in 2007 due to Cardiotoxicity."}
{"id":"CHEMBL128","canonicalSmiles":"CNS(=O)(=O)Cc1ccc2[nH]cc(CCN(C)C)c2c1","inchiKey":"KQKPFRSPSRPDEB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SUMATRIPTAN","yearOfFirstApproval":1992,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Imitrex","Sumatriptan","Tosymra"],"synonyms":["N02CC01","Sumatriptan"],"crossReferences":{"DailyMed":["sumatriptan","sumatriptan%20succinate"],"PubChem":["144205081","170465377","49679316"],"Wikipedia":["Sumatriptan"],"drugbank":["DB00669"],"chEBI":["10650"]},"childChemblIds":["CHEMBL1201150"],"linkedTargets":{"rows":["ENSG00000135312","ENSG00000179546"],"count":2},"linkedDiseases":{"rows":["MONDO_0100431","MONDO_0005277","EFO_0001073","EFO_0003843","HP_0002315","MONDO_0005475"],"count":6},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1992 and is indicated for migraine disorder and has 3 investigational indications."}
{"id":"CHEMBL1289601","canonicalSmiles":"COc1cc2nccc(Oc3ccc(NC(=O)NC4CC4)c(Cl)c3)c2cc1C(N)=O","inchiKey":"WOSKHXYHFSIKNG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LENVATINIB","yearOfFirstApproval":2015,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Kisplyx","Lenvima"],"synonyms":["E-7080","ER-203492-00","Lenvatinib"],"crossReferences":{"DailyMed":["lenvatinib%20mesylate"],"PubChem":["137276042"],"Wikipedia":["Lenvatinib"],"drugbank":["DB09078"],"chEBI":["85994"]},"childChemblIds":["CHEMBL3527309","CHEMBL2105704"],"linkedTargets":{"rows":["ENSG00000128052","ENSG00000102755","ENSG00000037280"],"count":3},"linkedDiseases":{"rows":["MONDO_0003060","EFO_0003891","EFO_0000637","EFO_1000592","EFO_0000756","EFO_0000681","EFO_0000571","EFO_1000261","EFO_1000657","EFO_0000228","EFO_0000178","EFO_0000588","MONDO_0002974","EFO_0000182","EFO_0000501","EFO_0008528","EFO_0000641","EFO_0005922","MONDO_0002108","MONDO_0008170","EFO_0000349","MONDO_0044915","EFO_0005221","MONDO_0008315","EFO_1000489","EFO_0003841","MONDO_0000544","MONDO_0000831","EFO_0000574","EFO_1000613","EFO_1000796","EFO_0003086","EFO_1001901","MONDO_0007254","EFO_0004230","EFO_1001012","EFO_0000231","MONDO_0001056","EFO_0000326","EFO_0002617","EFO_1000158","EFO_0000616","EFO_1000616","EFO_0000478","MONDO_0007576","EFO_0003060","EFO_0000311","EFO_1001961","EFO_1001471","MONDO_0002120","EFO_0002892","EFO_0002517","MONDO_0011962","EFO_0001421","EFO_0000702","EFO_0004142","EFO_0000691","EFO_0000181"],"count":58},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2015 and has 6 approved and 41 investigational indications."}
{"id":"CHEMBL1352","canonicalSmiles":"O=[N+]([O-])O","inchiKey":"GRYLNZFGIOXLOG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NITRIC ACID","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Nitrate","Nitric acid"],"crossReferences":{"PubChem":["564240"],"Wikipedia":["Nitric_acid"],"chEBI":["48107"]},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 8 investigational indications."}
{"id":"CHEMBL1355","canonicalSmiles":"O=C([O-])CC(O)(CC(=O)[O-])C(=O)[O-].[Na+].[Na+].[Na+]","inchiKey":"HRXKRNGNAMMEHJ-UHFFFAOYSA-K","drugType":"Small molecule","blackBoxWarning":false,"name":"SODIUM CITRATE","yearOfFirstApproval":1983,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Anticoagulant Sodium Citrate","Canesten oasis","Cymalon","Cystemme","Cystocalm","Cystoleve","Isolyte E","Micolette","Micralax","Relaxit","Sod cit","Urisal"],"synonyms":["Anhydrous sodium citrate","Anhydrous trisodium citrate","Anticoagulant sodium citrate","Citric acid, trisodium salt","Citrosodine","E-331(III)","E331","FEMA NO. 3026","FEMA NO. 3026, ANHYDROUS-","INS NO.331(III)","INS-331(III)","N-1560","Natrii citras","Natrii citras, dehydrate","Natrocitral","Sodium citrate","Sodium citrate anhydrous","Sodium citrate dihydrate","Sodium citrate hydrate","Sodium citrate hydrous","Sodium citrate, anhydrous","Sodium citrate,anhydrous","Trisodium citrate, anhydrous"],"crossReferences":{"DailyMed":["sodium%20citrate"],"DrugCentral":["4477"],"Wikipedia":["Monosodium_citrate","Trisodium_citrate"],"drugbank":["DB09154"],"chEBI":["53258"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1983 and is indicated for unipolar depression and anemia (phenotype) and has 7 investigational indications."}
{"id":"CHEMBL14012","canonicalSmiles":"CC(C)c1ccccc1OCC1=NCCN1","inchiKey":"GFYSWQDCHLWRMQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FENOXAZOLINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Fenoxazoline"],"crossReferences":{"drugbank":["DB13736"]},"childChemblIds":["CHEMBL2106595"],"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL14060","canonicalSmiles":"Oc1ccccc1","inchiKey":"ISWSIDIOOBJBQZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PHENOL","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Chloraseptic","S.b. ward"],"synonyms":["2-allphenol","Carbolic acid","Carbolicum acidum","ENT-1814","Liquefied phenol","Liquified phenol","NSC-36808","Phenic acid","Phenol","Phenol, liquefied","Phenol, liquified","Phenol,liquified","Phenylic alcohol","Salicylic acid related compound c"],"crossReferences":{"PubChem":["144207012","144208837","144210362","170465486","17389767","26753012","26753013"],"Wikipedia":["Phenol"],"drugbank":["DB03255"],"chEBI":["15882"]},"childChemblIds":["CHEMBL2107497"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and has 4 approved and 4 investigational indications."}
{"id":"CHEMBL14227","canonicalSmiles":"CCCC(=O)O","inchiKey":"FERIUCNNQQJTOY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BUTANOIC ACID","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Butanoic acid"],"crossReferences":{"PubChem":["144209580","144210484"],"Wikipedia":["Butyric_acid"],"drugbank":["DB03568"],"chEBI":["30772"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL142635","canonicalSmiles":"COc1ccccc1N1CCN(CC(O)COc2cccc3ccccc23)CC1","inchiKey":"HRRBJVNMSRJFHQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NAFTOPIDIL","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Flivas","NSC-759293","Naftopidil"],"crossReferences":{"PubChem":["104171197","144203756","170466026","26719853","26751791","49681769","50104483","90340768"],"drugbank":["DB12092"]},"childChemblIds":["CHEMBL1257069","CHEMBL1532139","CHEMBL1593765"],"linkedTargets":{"rows":["ENSG00000171873"],"count":1},"linkedDiseases":{"rows":["EFO_0004253","EFO_0000284","EFO_0000536"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL1492","canonicalSmiles":"CN1CCC(OC(c2ccccc2)c2ccccc2)CC1","inchiKey":"OWQUZNMMYNAXSL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DIPHENYLPYRALINE","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Diphenylpyraline"],"crossReferences":{"PubChem":["11112289","50123603","50123604"],"Wikipedia":["Diphenylpyraline"],"drugbank":["DB01146"],"chEBI":["59788"]},"childChemblIds":["CHEMBL1564"],"linkedTargets":{"rows":["ENSG00000196639"],"count":1},"linkedDiseases":{"rows":["MONDO_0005271"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1982 and is indicated for allergic disease."}
{"id":"CHEMBL15245","canonicalSmiles":"COC(=O)[C@H]1[C@@H](O)CC[C@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@@H]21","inchiKey":"BLGXFZZNTVWLAY-SCYLSFHTSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"YOHIMBINE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Yohimbine","Yohimbinum"],"crossReferences":{"PubChem":["144203570","170465467","46501178","90340710"],"Wikipedia":["Yohimbine"],"drugbank":["DB01392"],"chEBI":["10093"]},"childChemblIds":["CHEMBL537669"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and is indicated for erectile dysfunction and has 13 investigational indications."}
{"id":"CHEMBL152649","canonicalSmiles":"Cc1nc2ccccc2n1Cc1ccc(Cl)cc1","inchiKey":"WNAQOLSMVPFGTE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHLORMIDAZOLE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Chlormidazole"],"crossReferences":{"PubChem":["144205352","170466499","29216097","50085890"],"drugbank":["DB13611"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1618102","canonicalSmiles":"CCCC[N+]1(C)[C@H]2C[C@H](OC(=O)[C@H](CO)c3ccccc3)C[C@@H]1[C@H]1O[C@@H]21","inchiKey":"YBCNXCRZPWQOBR-WVHCHWADSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BUTYLSCOPOLAMINE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Butylscopolamine","N-butylscopolammonium","N-butylscopolammonium cation","N-butylscopolammonium ion"],"crossReferences":{"drugbank":["DB09300"]},"childChemblIds":["CHEMBL1256901"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and is indicated for gastrointestinal disease and has 1 investigational indication."}
{"id":"CHEMBL1743081","drugType":"Antibody","blackBoxWarning":false,"name":"TRALOKINUMAB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CAT-354","Tralokinumab"],"linkedTargets":{"rows":["ENSG00000169194"],"count":1},"linkedDiseases":{"rows":["EFO_0002618","EFO_0000729","EFO_0004192","HP_0000964","EFO_0000768","MONDO_0004979","EFO_0000274"],"count":7},"description":"Antibody drug with a maximum clinical trial phase of III (across all indications) and has 7 investigational indications."}
{"id":"CHEMBL1888176","canonicalSmiles":"O=C(O[C@@H]1C[C@@H]2CC[C@H](C1)[N+]21CCCC1)C(O)(c1ccccc1)c1ccccc1","inchiKey":"OYYDSUSKLWTMMQ-JKHIJQBDSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TROSPIUM","yearOfFirstApproval":2004,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Trospium","Trospium cation","Trospium ion"],"crossReferences":{"DailyMed":["trospium%20chloride"],"PubChem":["50112692"],"drugbank":["DB00209"]},"childChemblIds":["CHEMBL3084748"],"linkedTargets":{"rows":["ENSG00000133019","ENSG00000181072"],"count":2},"linkedDiseases":{"rows":["MONDO_0005090","EFO_0006865","HP_0000020","EFO_1000781","EFO_0000341","HP_0000103"],"count":6},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2004 and has 4 approved and 3 investigational indications."}
{"id":"CHEMBL1908365","canonicalSmiles":"OC[C@H]1O[C@H](O[C@@H]2[C@@H](CO)O[C@@H](O)[C@H](O)[C@H]2O)[C@H](O)[C@@H](O)[C@@H]1O","inchiKey":"GUBGYTABKSRVRQ-QUYVBRFLSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MALTOSE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Maltose","Maltose anhydrous","Maltose, unspecified form","NSC-760396"],"crossReferences":{"chEBI":["18147"]},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL1929396","canonicalSmiles":"Cc1cc2ncc(C(=O)NCC(C)(C)NCC(=O)N3CCC[C@H]3C#N)cn2n1","inchiKey":"LDXYBEHACFJIEL-HNNXBMFYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ANAGLIPTIN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Anagliptin","CWP-403","SK-0403","Sk-0403","Suiny"],"crossReferences":{"drugbank":["DB12417"]},"childChemblIds":["CHEMBL1929387"],"linkedTargets":{"rows":["ENSG00000197635"],"count":1},"linkedDiseases":{"rows":["MONDO_0005148"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL2009089","canonicalSmiles":"O=[Se](O)O","inchiKey":"MCAHWIHFGHIESP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SELENIOUS ACID","yearOfFirstApproval":2019,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Monohydrated selenium dioxide","Selenious acid","Selenium (as selenious acid)","Selenium dioxide, monohydrated","UN 3283","UN-3283"],"crossReferences":{"DailyMed":["selenious%20acid"],"PubChem":["144207605"],"drugbank":["DB11127"],"chEBI":["26642"]},"childChemblIds":["CHEMBL2028294","CHEMBL112302"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2019 and has 7 investigational indications."}
{"id":"CHEMBL205792","canonicalSmiles":"COc1cc(-c2cccc(N)c2)c2oc(NS(=O)(=O)c3cc(Cl)ccc3Cl)nc2c1","inchiKey":"GAYYMURZGLJDCT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL205792","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07270"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2096639","canonicalSmiles":"CC[C@H](C)[C@H](N)C1=N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCC(=O)[O-])C(=O)N[C@H](C(=O)N[C@H]2CCCCNC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](CC(=O)[O-])NC(=O)[C@H](Cc3cnc[nH]3)NC(=O)[C@@H](Cc3ccccc3)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@@H](CCCN)NC2=O)[C@@H](C)CC)CS1.[Zn+2]","inchiKey":"UCRLQOPRDMGYOA-DFTDUNEMSA-L","drugType":"Protein","blackBoxWarning":false,"name":"BACITRACIN ZINC","yearOfFirstApproval":1957,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1200558","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Ziba-rx"],"synonyms":["Bacifarmin","Bacitracin zinc","Bacitracins zinc complex","Bacitracins, zinc complex","Bacitracinum zincum","Noptracin","Zinc bacitracin"],"crossReferences":{"DailyMed":["bacitracin%20zinc"]},"description":"Protein drug with a maximum clinical trial phase of IV that was first approved in 1957 and is indicated for inflammation."}
{"id":"CHEMBL2104261","canonicalSmiles":"Cc1ccc(/C=C2/C(=O)C3(C)CCC2C3(C)C)cc1","inchiKey":"HEOCBCNFKCOKBX-SDNWHVSQSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ENZACAMENE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["50112672"],"drugbank":["DB11219"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2105248","canonicalSmiles":"O=C([O-])[C@H](O)[C@@H](O)C(=O)O.[K+]","inchiKey":"KYKNRZGSIGMXFH-ZVGUSBNCSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"POTASSIUM BITARTRATE","yearOfFirstApproval":2020,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Acid potassium tartrate","E-336(I)","Faecla","Faecula","INS NO.336(I)","INS-336(I)","Monopotassium tartrate (336(i))","NSC-155080","Potassium acid tartrate","Potassium bitartrate","Potassium hydrogen tartrate","Potassium hydrogentartrate","Purified cream of tartar"],"crossReferences":{"DailyMed":["potassium%20bitartrate"],"DrugCentral":["4694"],"drugbank":["DB11107"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 2020."}
{"id":"CHEMBL2105638","canonicalSmiles":"CNC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.Nc1nc(-n2cc(C(=O)O)c(=O)c3cc(F)c(N4CC(O)C4)c(Cl)c32)c(F)cc1F","inchiKey":"AHJGUEMIZPMAMR-WZTVWXICSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"DELAFLOXACIN MEGLUMINE","yearOfFirstApproval":2017,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL2105637","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Baxdela"],"synonyms":["ABT-492","Delafloxacin meglumine","RX-3341","Rx-3341 meglumine","WQ-3034","WQ-3034 AND ABT-492","Wq-3034 meglumine"],"crossReferences":{"DailyMed":["delafloxacin%20meglumine"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 2017 and is indicated for skin disease. This drug has a black box warning from the FDA."}
{"id":"CHEMBL2105972","canonicalSmiles":"CC[N+](C)(C)CCC(C(N)=O)(c1ccccc1)c1ccccc1.[Br-]","inchiKey":"VTAGVKVPFBOVRM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AMBUTONIUM BROMIDE","maximumClinicalTrialPhase":4,"parentId":"CHEMBL2110771","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Aludrox sa","Gppe susp"],"synonyms":["Ambutonium bromide"],"description":"Small molecule drug with a maximum clinical trial phase of IV."}
{"id":"CHEMBL2106065","canonicalSmiles":"CCN(CC)CCCNCc1cc(Cl)c2cccnc2c1O.Cl","inchiKey":"MHQRIKBJCFNCIH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CLAMOXYQUIN HYDROCHLORIDE","maximumClinicalTrialPhase":3,"parentId":"CHEMBL2110791","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Clamoxyl"],"synonyms":["CI-433","CN-17,900-2B","CN-17900-2B","Clamoxyquin dihydrochloride","Clamoxyquin hcl","Clamoxyquin hydrochloride","Clamoxyquine hydrochloride","NSC-20246","PAA-3854"],"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2106195","canonicalSmiles":"Cc1cccc([C@H](C)c2c[nH]cn2)c1C.Cl","inchiKey":"VPNGEIHDPSLNMU-MERQFXBCSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DEXMEDETOMIDINE HYDROCHLORIDE","yearOfFirstApproval":1999,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL778","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Dexmedetomidine hydrochloride","Precedex"],"synonyms":["Cepedex","Dexdomitor","Dexdor","Dexmedetomidine hcl","Dexmedetomidine hydrochloride","Sedadex","Sileo"],"crossReferences":{"DailyMed":["dexmedetomidine%20hydrochloride"],"chEBI":["31472"]},"linkedTargets":{"rows":["ENSG00000274286","ENSG00000184160","ENSG00000150594"],"count":3},"linkedDiseases":{"rows":["MONDO_0005090","EFO_0003777","EFO_0000278","EFO_1001454","EFO_0009267","MONDO_0043510","EFO_0003843","EFO_0005411","HP_0000713"],"count":9},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1999 and has 6 investigational indications."}
{"id":"CHEMBL2107830","canonicalSmiles":"OC[C@H]1O[C@@H](c2ccc(Cl)c(Cc3ccc(O[C@H]4CCOC4)cc3)c2)[C@H](O)[C@@H](O)[C@@H]1O","inchiKey":"OBWASQILIWPZMG-QZMOQZSNSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"EMPAGLIFLOZIN","yearOfFirstApproval":2014,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Bi 10773","Jardiance"],"synonyms":["BI 10773","BI-10773","Empagliflozin"],"crossReferences":{"DailyMed":["empagliflozin"],"drugbank":["DB09038"],"chEBI":["82720"]},"linkedTargets":{"rows":["ENSG00000140675"],"count":1},"linkedDiseases":{"rows":["EFO_0003086","EFO_0000729","EFO_0003095","EFO_1001984","EFO_0000401","EFO_0004997","EFO_0004593","EFO_0003144","HP_0002902","EFO_0003884","EFO_0004253","EFO_0000400","EFO_0000694","EFO_0000319","EFO_0004194","EFO_0000666","EFO_0001073","EFO_0000384","EFO_0000660","EFO_0000537","HP_0012664","EFO_1001482","EFO_0002614","Orphanet_364","MONDO_0005147","EFO_1001121","EFO_0008583","EFO_0000612","HP_0001943","MONDO_0005148","EFO_1000982"],"count":31},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2014 and is indicated for diabetes mellitus and type 2 diabetes mellitus and has 16 investigational indications."}
{"id":"CHEMBL2107842","drugType":"Protein","blackBoxWarning":false,"name":"ALBINTERFERON ALFA-2B","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Albuferon"],"synonyms":["Albinterferon alfa-2b","Interferon-alfa-2b"],"linkedTargets":{"rows":["ENSG00000159110","ENSG00000142166"],"count":2},"linkedDiseases":{"rows":["EFO_0004220","EFO_0003047","EFO_0004239"],"count":3},"description":"Protein drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL2107943","drugType":"Small molecule","blackBoxWarning":false,"name":"POLIDEXIDE SULFATE","yearOfFirstApproval":1974,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["United Kingdom"],"year":1975},"tradeNames":[],"synonyms":["Deae-sephadex","Polidexide","Polidexide sulfate"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1974. It was withdrawn in United Kingdom  in 1975."}
{"id":"CHEMBL2108234","drugType":"Small molecule","blackBoxWarning":false,"name":"COD LIVER OIL","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Ashtons","Callanish","Ennogen","First choice","Good health","Healthchecks","House of health","Morhulin","Natrahealth","Neutraceuticals","Noratex","Peel","Primacy","Quest","Thovaline","Total body care","Totavit","Valuvit","Willowcare preps"],"synonyms":["Cod liver oil","Oleum morrhuae"],"description":"Small molecule drug with a maximum clinical trial phase of IV."}
{"id":"CHEMBL2108724","drugType":"Protein","blackBoxWarning":true,"name":"SEMAGLUTIDE","yearOfFirstApproval":2017,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Ozempic","Rybelsus","Wegovy"],"synonyms":["NN-9535","NN9535","NNC 0113-0217","NNC-0113-0217","Nn9535","Semaglutide"],"crossReferences":{"DailyMed":["semaglutide"]},"linkedTargets":{"rows":["ENSG00000112164"],"count":1},"linkedDiseases":{"rows":["HP_0000938","EFO_0003095","MONDO_0002009","EFO_1001121","MONDO_0005180","MONDO_0005147","EFO_0001645","MONDO_0004975","EFO_1001249","MONDO_0004979","EFO_0000400","MONDO_0005148","EFO_0001073"],"count":13},"description":"Protein drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2017 and is indicated for type 2 diabetes mellitus and diabetes mellitus and has 8 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL2109604","drugType":"Antibody","blackBoxWarning":false,"name":"MEDI-2338","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AEVI-007","Aevi-007","CERC-007","MEDI-2338","MEDI2338","Medi-2338"],"linkedTargets":{"rows":["ENSG00000150782"],"count":1},"linkedDiseases":{"rows":["EFO_0007135","EFO_0001378","EFO_0000341"],"count":3},"description":"Antibody drug with a maximum clinical trial phase of I (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL230006","canonicalSmiles":"CC1(C)[C@@H](O)CC[C@@]2(C)[C@H]1CC[C@]1(C)[C@@H]2C(=O)C=C2[C@@H]3C[C@@](C)(C(=O)O)CC[C@]3(C)CC[C@]21C","inchiKey":"MPDGHEJMBKOTSU-YKLVYJNSSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ENOXOLONE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Enoxolone","Glycyrrhetic acid","NSC-35347","NSC-35350","Rhetinic acid","Uralenic acid"],"crossReferences":{"PubChem":["104171338","11533025","144204355","144206279","144207997","26754257","29215195","56424132"],"Wikipedia":["Glycyrrhetinic_acid"],"drugbank":["DB13089"],"chEBI":["30853"]},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL232827","canonicalSmiles":"c1cn(-c2ccc(O[C@H]3CCCN(Cc4ccc5c(c4)OCO5)C3)cc2)cn1","inchiKey":"HHOPJGKEAIIIDF-FQEVSTJZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL232827","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07011"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL24646","canonicalSmiles":"COc1ccc(-c2nc3cc(C4=NNC(=O)CC4C)ccc3[nH]2)cc1","inchiKey":"GLBJJMFZWDBELO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PIMOBENDAN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Acardi","Dl-pimobendan","Pimobendan","Pimobendane","Racemic pimobendan","UD-CG-115","UD-CG-115BS","UDCG-115","Vetmedin"],"crossReferences":{"PubChem":["174007050"],"Wikipedia":["Pimobendan"],"drugbank":["DB11450"],"chEBI":["32003"]},"childChemblIds":["CHEMBL2354434"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL250787","canonicalSmiles":"C[C@@H]1c2nc(C(F)(F)F)nn2CCN1C(=O)C[C@H](N)Cc1cc(F)c(F)cc1F","inchiKey":"FDEXEPZGMKFCTG-PSASIEDQSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL250787","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07081"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL255465","canonicalSmiles":"NC1=N/C(=C2/CCNC(=O)c3[nH]ccc32)C(=O)N1","inchiKey":"JYRJOQGKGMHTOO-VURMDHGXSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DEBROMOHYMENIALDISINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["(Z)-2-Debromohymenialdisine","Debromohymenialdisine"],"crossReferences":{"drugbank":["DB04367"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL27810","canonicalSmiles":"CCN(CC)C(=O)Nc1ccc(OCC(O)CNC(C)(C)C)c(C(C)=O)c1","inchiKey":"JOATXPAWOHTVSZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CELIPROLOL","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Celiprolol","Celiprolol pch"],"crossReferences":{"Wikipedia":["Celiprolol"],"drugbank":["DB04846"]},"childChemblIds":["CHEMBL1742424"],"linkedTargets":{"rows":["ENSG00000184160","ENSG00000274286","ENSG00000169252","ENSG00000043591","ENSG00000150594"],"count":5},"linkedDiseases":{"rows":["Orphanet_286","EFO_0000341","EFO_0000319"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for cardiovascular disease."}
{"id":"CHEMBL286013","canonicalSmiles":"CCC(C)(C)C(=O)O","inchiKey":"VUAXHMVRKOTJKP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"2,2-DIMETHYLBUTYRATE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["2,2-Dimethyl-Butyric Acid"],"crossReferences":{"PubChem":["144207938","17389426","56462806"],"chEBI":["38649"]},"childChemblIds":["CHEMBL1650317"],"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL290077","canonicalSmiles":"Nc1nc(F)nc2c1ncn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O","inchiKey":"HBUBKKRHXORPQB-UUOKFMHZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL290077","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["47193876","50125930"],"drugbank":["DB04441"],"chEBI":["39740"]},"childChemblIds":["CHEMBL1780215"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL290352","canonicalSmiles":"CCSCc1ccc2c(c1)c1c3c(c4c5cc(CSCC)ccc5n5c4c1n2[C@H]1C[C@](O)(C(=O)OC)[C@]5(C)O1)CNC3=O","inchiKey":"SCMLRESZJCKCTC-KMYQRJGFSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CEP-1347","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CEP-1347","Cep-1347","KT-1575","KT-7515","KT7515"],"linkedTargets":{"rows":["ENSG00000139625","ENSG00000130758","ENSG00000006432","ENSG00000073803","ENSG00000173327"],"count":5},"linkedDiseases":{"rows":["MONDO_0005180"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL30008","canonicalSmiles":"Fc1ccc(C(c2ccc(F)cc2)N2CCN(C/C=C/c3ccccc3)CC2)cc1","inchiKey":"SMANXXCATUTDDT-QPJJXVBHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FLUNARIZINE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Flunarizine"],"crossReferences":{"PubChem":["104171359","124883266","144204376","170466037","26751607","26751608","50104264","50104265","90341204"],"Wikipedia":["Flunarizine"],"drugbank":["DB04841"]},"childChemblIds":["CHEMBL539027","CHEMBL552659"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and is indicated for vertigo and has 1 investigational indication."}
{"id":"CHEMBL3039545","drugType":"Protein","blackBoxWarning":false,"name":"LUSPATERCEPT","yearOfFirstApproval":2019,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Reblozyl"],"synonyms":["ACE-536","Luspatercept","Luspatercept-aamt"],"crossReferences":{"DailyMed":["luspatercept-aamt"]},"linkedTargets":{"rows":["ENSG00000105329","ENSG00000119699","ENSG00000092969"],"count":3},"linkedDiseases":{"rows":["EFO_0000198","EFO_0002430","EFO_0004251","MONDO_0044903","MONDO_0002280","EFO_1001996","EFO_0004272","Orphanet_848","EFO_0002429","EFO_1000388"],"count":10},"description":"Protein drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2019 and has 5 approved and 5 investigational indications."}
{"id":"CHEMBL3040192","canonicalSmiles":"CC(=O)NCSC[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCC(=O)O)[C@@H](C)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CSCNC(C)=O)C(=O)N[C@H](C(=O)N[C@@H](CSCNC(C)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O","inchiKey":"ZRXXHPDJLAQCPC-SFJRRRFZSA-N","drugType":"Protein","blackBoxWarning":false,"name":"TIGAPOTIDE","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["PCK-3145","Tigapotide"],"childChemblIds":["CHEMBL2369994"],"description":"Protein drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL305660","canonicalSmiles":"CC(C)(C)c1ccc(C(=O)CCCN2CCC(OC(c3ccccc3)c3ccccc3)CC2)cc1","inchiKey":"MJJALKDDGIKVBE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"EBASTINE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Kestine"],"synonyms":["Ebastine","LAS W-090","LAS-W-090","RP 64305","RP-64305"],"crossReferences":{"PubChem":["144205778","170465995","26758025","90340626"],"Wikipedia":["Ebastine"],"drugbank":["DB11742"]},"linkedTargets":{"rows":["ENSG00000196639"],"count":1},"linkedDiseases":{"rows":["EFO_0005531","EFO_0000555","MONDO_0005271"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL325029","canonicalSmiles":"C=CCOC(=O)N[C@@H](Cc1ccc(N(C(=O)C(=O)O)c2ccccc2C(=O)O)cc1)C(=O)NCCCCOc1cccc(O)c1C(=O)OC","inchiKey":"JTJBRKLISQICDU-DEOSSOPVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL325029","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB04088"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL326523","canonicalSmiles":"C#CCCCn1c(Cc2cc(OC)c(OC)c(OC)c2Cl)nc2c(N)ncnc21","inchiKey":"WUJFGZAAFADPSF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL326523","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB04505"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL326611","canonicalSmiles":"O=C(Nc1ccccc1Oc1ccc(C(=O)O)c(C(=O)O)c1)c1cccc([N+](=O)[O-])c1","inchiKey":"NAQUAVBNIYTIIS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL326611","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB04044"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL328560","canonicalSmiles":"NS(=O)(=O)c1ccc(N2CCCCS2(=O)=O)cc1","inchiKey":"HMHVCUVYZFYAJI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SULTHIAME","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Conadil","Ospolot","Trolone"],"synonyms":["RIKER 594","RIKER-594","Sulthiame","Sultiame"],"crossReferences":{"PubChem":["170465788"],"Wikipedia":["Sultiame"],"drugbank":["DB08329"],"chEBI":["32171"]},"linkedTargets":{"rows":["ENSG00000174990","ENSG00000167434","ENSG00000169239","ENSG00000118298","ENSG00000168748","ENSG00000133742","ENSG00000164879","ENSG00000104267","ENSG00000107159","ENSG00000185015","ENSG00000131686","ENSG00000074410"],"count":12},"linkedDiseases":{"rows":["EFO_0000474","EFO_0003918"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for epilepsy."}
{"id":"CHEMBL3301585","drugType":"Antibody","blackBoxWarning":false,"name":"PINATUZUMAB VEDOTIN","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ACD-22-VCMMAE","ACD-22VCMMAE","ACD22-VCMMAE","DCDT-2980S","DCDT2980S","FCU-2703","FCU2703","Pinatuzumab vedotin","RG-7593","RO-5541072-000","RO-5541072000","RO5541072-000"],"linkedTargets":{"rows":["ENSG00000261456","ENSG00000012124","ENSG00000188229","ENSG00000104833","ENSG00000137267","ENSG00000258947","ENSG00000101162","ENSG00000196230","ENSG00000137285","ENSG00000176014"],"count":10},"linkedDiseases":{"rows":["EFO_0000095","EFO_0000403","MONDO_0018906"],"count":3},"description":"Antibody drug with a maximum clinical trial phase of I (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL333826","canonicalSmiles":"Cc1cc(N)c2ccccc2[n+]1CCCCCCCCCC[n+]1c(C)cc(N)c2ccccc21","inchiKey":"PCSWXVJAIHCTMO-UHFFFAOYSA-P","drugType":"Small molecule","blackBoxWarning":false,"name":"DEQUALINIUM","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Dequalinium","Dequalinium cation"],"crossReferences":{"PubChem":["11111064","11111065","11113637","124879872","225144172","50104538","90340946"],"Wikipedia":["Dequalinium"],"drugbank":["DB04209"],"chEBI":["41872"]},"childChemblIds":["CHEMBL1256847","CHEMBL121663"],"description":"Small molecule drug with a maximum clinical trial phase of IV and has 1 investigational indication."}
{"id":"CHEMBL351706","canonicalSmiles":"N#Cc1ccc2c(c1)CN(S(=O)(=O)c1cccs1)[C@H](Cc1ccccc1)CN2Cc1c[nH]cn1","inchiKey":"OLCWFLWEHWLBTO-HSZRJFAPSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BMS-214662","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BMS-214662","Bms 214662","Bms-214662"],"crossReferences":{"drugbank":["DB12234"]},"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL3544996","drugType":"Antibody","blackBoxWarning":false,"name":"IDARUCIZUMAB","yearOfFirstApproval":2015,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Praxbind"],"synonyms":["Adabi-fab","BI 655075","BI-655075","BI655075","Idarucizumab"],"crossReferences":{"DailyMed":["idarucizumab"],"DrugCentral":["5055"]},"description":"Antibody drug with a maximum clinical trial phase of IV that was first approved in 2015 and is indicated for hemorrhage."}
{"id":"CHEMBL3545032","drugType":"Small molecule","blackBoxWarning":false,"name":"PF-04634817","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Pf-04634817"],"linkedTargets":{"rows":["ENSG00000160791","ENSG00000121807"],"count":2},"linkedDiseases":{"rows":["HP_0000083","EFO_0000401","EFO_0009321"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL3545188","canonicalSmiles":"NCCCC[C@@H]1NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](c2ccccc2)NC(=O)[C@@H]2C[C@H](OC(=O)NCCN)CN2C(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(OCc3ccccc3)cc2)NC1=O.O=C(O)c1cc2ccccc2c(Cc2c(O)c(C(=O)O)cc3ccccc23)c1O","inchiKey":"HSXBEUMRBMAVDP-NEOZNVFSSA-N","drugType":"Protein","blackBoxWarning":false,"name":"PASIREOTIDE PAMOATE","yearOfFirstApproval":2014,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL3039583","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Signifor lar","Signifor lar kit"],"synonyms":["Pasireotide embonate","Pasireotide pamoate"],"linkedTargets":{"rows":["ENSG00000162009","ENSG00000278195","ENSG00000139874","ENSG00000180616"],"count":4},"linkedDiseases":{"rows":["EFO_1001485"],"count":1},"description":"Protein drug with a maximum clinical trial phase of IV that was first approved in 2014 and is indicated for acromegaly."}
{"id":"CHEMBL3545388","canonicalSmiles":"CCN1CCC(c2cc(F)cc(S(C)(=O)=O)c2)CC1","inchiKey":"PHRDGRSMZPOCAB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SERIDOPIDINE","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Acr343","Seridopidine"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3707207","drugType":"Oligosaccharide","blackBoxWarning":false,"name":"PARNAPARIN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Parnaparin"],"description":"Oligosaccharide drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL3707276","drugType":"Protein","blackBoxWarning":false,"name":"VOSORITIDE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BMN 111","BMN-111","Bmn 111","Vosoritide"],"linkedTargets":{"rows":["ENSG00000159899"],"count":1},"linkedDiseases":{"rows":["Orphanet_15","HP_0004322"],"count":2},"description":"Protein drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL3707294","drugType":"Antibody","blackBoxWarning":false,"name":"DEPATUXIZUMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ABT-806","Anti-egfr mab abt-806","Anti-egfr moab abt-806","Depatuxizumab"],"linkedTargets":{"rows":["ENSG00000146648"],"count":1},"linkedDiseases":{"rows":["EFO_0000616","EFO_0000228"],"count":2},"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL3989647","canonicalSmiles":"CC1(C)S[C@@H]2[C@H](NC(=O)[C@H](C(=O)O)c3ccsc3)C(=O)N2[C@H]1C(=O)[O-].O.[Na+]","inchiKey":"BVGLWBKHBMAPKY-QBGWIPKPSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"TICARCILLIN MONOSODIUM","maximumClinicalTrialPhase":3,"parentId":"CHEMBL1449","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ticarcillin monosodium","Ticarcillin monosodium monohydrate"],"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL3990021","drugType":"Antibody","blackBoxWarning":false,"name":"VADASTUXIMAB TALIRINE","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["SGN - CD33A","SGN-CD33A","SGNCD33A","Vadastuximab talirine"],"description":"Antibody drug with a maximum clinical trial phase of I (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL402262","canonicalSmiles":"NS(=O)(=O)c1cc([C@@]2(O)NC(=O)c3ccccc32)ccc1Cl","inchiKey":"JIVPVXMEBJLZRO-AWEZNQCLSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL402262","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["11112206"],"drugbank":["DB08046"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL403989","canonicalSmiles":"Cc1cc(-c2cc(OC(=O)c3ccccc3)ccc2Cl)cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12","inchiKey":"JMGXJHWTVBGOKG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TG100-801","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["TG100-801","Tg100-801"],"crossReferences":{"drugbank":["DB05075"]},"linkedTargets":{"rows":["ENSG00000128052","ENSG00000066468","ENSG00000113721","ENSG00000196411","ENSG00000010810","ENSG00000101336","ENSG00000000938","ENSG00000182866","ENSG00000102755","ENSG00000077782","ENSG00000254087","ENSG00000125508","ENSG00000136573","ENSG00000111816","ENSG00000176105","ENSG00000197122"],"count":16},"linkedDiseases":{"rows":["EFO_0009606","EFO_0004683","EFO_0003770"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL4068611","canonicalSmiles":"Cn1cc(S(=O)(=O)N2CCC3=Cc4c(cnn4-c4ccc(F)cc4)C[C@]3(C(=O)c3cc(C(F)(F)F)ccn3)C2)cn1","inchiKey":"WANIDIGFXJFFEL-SANMLTNESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RELACORILANT","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CORT125134","Cort 125134","Cort-125134","Relacorilant"],"crossReferences":{"drugbank":["DB14976"]},"linkedTargets":{"rows":["ENSG00000113580"],"count":1},"linkedDiseases":{"rows":["EFO_0000616","EFO_0003099","MONDO_0015686","EFO_0002517","EFO_1000251","MONDO_0008170","EFO_1000796","MONDO_0008315","EFO_1000797"],"count":9},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 8 investigational indications."}
{"id":"CHEMBL4297210","canonicalSmiles":"CC(C)(O)c1nc2ccc(Cl)cc2cc1N","inchiKey":"GUHFUVLKYSQIOQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"REPROXALAP","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ADX-102","ALD-102","NS2","Reproxalap"],"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL4297247","drugType":"Gene","blackBoxWarning":false,"name":"BIZALIMOGENE RALAPLASMID","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Bizalimogene ralaplasmid","PGX-3002","VGX-3100","pGX3002"],"description":"Gene drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4297612","name":"CHEMBL4297612","tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB14903"]}}
{"id":"CHEMBL4297645","canonicalSmiles":"CN[C@H](CC(C)C)C(=O)N[C@H]1C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]2C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)NCCCO/N=C(\\C(=O)N[C@@H]4C(=O)N5C(C(=O)[O-])=C(C[n+]6ccccc6)CS[C@H]45)c4nc(N)sc4Cl)c4cc(O)cc(O)c4-c4cc3ccc4O)[C@H](O)c3ccc(c(Cl)c3)Oc3cc2cc(c3O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O[C@H]2C[C@](C)(N)[C@H](O)[C@H](C)O2)Oc2ccc(cc2Cl)[C@H]1O","inchiKey":"OGUAFUAJSPORAH-KHCCTVBNSA-N","drugType":"Unknown","blackBoxWarning":false,"name":"CEFILAVANCIN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Cefilavancin","TD-1792","Td-1792"],"description":"Unknown drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4298085","drugType":"Antibody","blackBoxWarning":false,"name":"FIANLIMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Fianlimab","REGN-3767","REGN3767","Regn3767"],"linkedTargets":{"rows":["ENSG00000089692"],"count":1},"linkedDiseases":{"rows":["EFO_0003968","EFO_0005537","EFO_0000311"],"count":3},"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL4594288","canonicalSmiles":"CCOC(=O)C1=C(COCCN)NC(C)=C(C(=O)OC)[C@@H]1c1ccccc1Cl.O=C(O)/C=C\\C(=O)O","inchiKey":"TZNOWAJJWCGILX-HNUXRKMMSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LEVAMLODIPINE MALEATE","yearOfFirstApproval":2019,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL2111097","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Conjupri"],"synonyms":["Amlodipine maleate, s-","Levamlodipine maleate"],"crossReferences":{"DailyMed":["levamlodipine%20maleate"]},"linkedTargets":{"rows":["ENSG00000157388","ENSG00000081248","ENSG00000102001","ENSG00000151067"],"count":4},"linkedDiseases":{"rows":["EFO_0000537"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 2019 and is indicated for hypertension."}
{"id":"CHEMBL4594381","canonicalSmiles":"[2H]C1([2H])C([C@@H](CC#N)n2cc(-c3ncnc4[nH]ccc34)cn2)C([2H])([2H])C([2H])([2H])C1([2H])[2H]","inchiKey":"HFNKQEVNSGCOJV-FBXGHSCESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DEURUXOLITINIB","maximumClinicalTrialPhase":3,"parentId":"CHEMBL1789941","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["C-21543","CTP-543","D8-ruxolitinib","Deuruxolitinib"],"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL4594505","drugType":"Antibody","blackBoxWarning":false,"name":"TECLISTAMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BCMAxCD3","JNJ-64007957","Jnj 64007957","Teclistamab"],"linkedTargets":{"rows":["ENSG00000167286","ENSG00000048462","ENSG00000160654","ENSG00000198851"],"count":4},"linkedDiseases":{"rows":["EFO_0001642","EFO_0001378","EFO_0000311"],"count":3},"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL4594537","drugType":"Unknown","blackBoxWarning":false,"name":"DNL-310","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["DNL-310","DNL310","Dnl-310","Dnl310","Etv:ids"],"description":"Unknown drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4594590","drugType":"Protein","blackBoxWarning":false,"name":"EFINEPTAKIN ALFA","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Efineptakin alfa","Hyleukin","NT-I7","Nt-i7","Recombinant human il-7-hyfc (nt-i7)"],"description":"Protein drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL463763","canonicalSmiles":"CC(C)[C@]12O[C@H]1[C@@H]1O[C@@]13[C@@]1(C)CCC4=C(COC4=O)[C@@H]1C[C@@H]1O[C@@]13[C@@H]2O","inchiKey":"DFBIRQPKNDILPW-CIVMWXNOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TRIPTOLIDE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["NSC-163062","Triptolide"],"crossReferences":{"PubChem":["26719814","26756783","26756784","438041","49681800"],"drugbank":["DB12025"],"chEBI":["9747"]},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL4650303","canonicalSmiles":"CC(C)(C[C@H](N)C(=O)O)C(F)F","inchiKey":"HRFIMCJTDKEPPV-BYPYZUCNSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NV-5138","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["NV-5138","Nv-5138"],"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4650315","canonicalSmiles":"CN(C)CC1CCCCC1(O)c1cccc(O)c1","inchiKey":"UWJUQVWARXYRCG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DESMETRAMADOL","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Desmetramadol","Mono-o-demethyltramadol","O-demethyltramadol","O-desmethyl tramadol","O-desmethyltramadol","O-dsmt"],"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4650322","canonicalSmiles":"C[C@H]([C@H](C(=O)Nc1cc([C@@H](CC(=O)O)C2CC2)ccc1Cl)c1ccc(Cl)cc1)C(F)(F)F","inchiKey":"NCRMKIWHFXSBGZ-CNBXIYLPSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RUNCACIGUAT","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Runcaciguat"],"linkedTargets":{"rows":["ENSG00000164116","ENSG00000061918","ENSG00000123201","ENSG00000152402"],"count":4},"linkedDiseases":{"rows":["EFO_0003884","EFO_0003770"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4650439","drugType":"Antibody","blackBoxWarning":false,"name":"LATOZINEMAB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AL-001","AL001","Al001","Latozinemab"],"description":"Antibody drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL473922","canonicalSmiles":"Nc1nc2c([C@@H]3N[C@H](CO)[C@@H](O)[C@H]3O)c[nH]c2c(=O)[nH]1","inchiKey":"KBIDJCVAURJXFG-PVEDRDFWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL473922","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02230"],"chEBI":["43467"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4802138","canonicalSmiles":"O[C@H]1CCCN[C@@H]1CCCn1cnc2c(Cl)c(Cl)ccc21","inchiKey":"VXCNMWNXDDMFSX-YPMHNXCESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DWN-12088","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["DWN-12088","DWN12088","Dwn-12088","Dwn12088"],"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4802154","canonicalSmiles":"Cn1ccc2c([C@H](Nc3cc(Cl)c4ncc(C#N)c(NCC(C)(C)C)c4c3)c3cn(C45CC(C4)C5)nn3)cccc2c1=O","inchiKey":"VFGSKBLZRDRHOI-ZAGPDIDGSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TILPISERTIB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Tilpisertib"],"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL511099","canonicalSmiles":"Cc1ccc(C23CNCC2C3)cc1","inchiKey":"OFYVIGTWSQPCLF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BICIFADINE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Bicifadine"],"crossReferences":{"drugbank":["DB04889"]},"childChemblIds":["CHEMBL544862"],"linkedTargets":{"rows":["ENSG00000108576","ENSG00000103546","ENSG00000142319"],"count":3},"linkedDiseases":{"rows":["EFO_1000783","HP_0003419"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL518520","canonicalSmiles":"Cc1nnc(C(=O)NC(C)(C)c2nc(C(=O)NCc3ccc(F)cc3)c([O-])c(=O)n2C)o1.[K+]","inchiKey":"IFUKBHBISRAZTF-UHFFFAOYSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"RALTEGRAVIR POTASSIUM","yearOfFirstApproval":2007,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL254316","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Isentress","Isentress hd"],"synonyms":["MK-0518","MK-0518 POTASSIUM","MK0518 POTASSIUM","Raltegravir monopotassium salt","Raltegravir potassium","Raltegravir potassium salt"],"crossReferences":{"DailyMed":["raltegravir%20potassium"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2007 and has 3 approved indications."}
{"id":"CHEMBL538867","canonicalSmiles":"CC1=C2C[C@H]3[C@@H](CC[C@@H]4C[C@H](NS(C)(=O)=O)CC[C@]34C)[C@@H]2CC[C@@]2(C1)O[C@@H]1C[C@H](C)CN[C@H]1[C@H]2C","inchiKey":"HZLFFNCLTRVYJG-WWGOJCOQSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PATIDEGIB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["FIN-5","IP-9","IP9 FREE BASE","IPI 926","IPI-926","IPI-926 FREE BASE","Ipi-926","Patidegib","Saridegib"],"crossReferences":{"Wikipedia":["IPI-926"],"drugbank":["DB12655"]},"childChemblIds":["CHEMBL2105764"],"linkedTargets":{"rows":["ENSG00000128602"],"count":1},"linkedDiseases":{"rows":["EFO_0002618","EFO_0000616","Orphanet_377","EFO_0004193","EFO_0000333"],"count":5},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL551466","canonicalSmiles":"O=C(O[C@H]1C[N+]2(CCCOc3ccccc3)CCC1CC2)C(O)(c1cccs1)c1cccs1.[Br-]","inchiKey":"XLAKJQPTOJHYDR-QTQXQZBYSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"ACLIDINIUM BROMIDE","yearOfFirstApproval":2012,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1194325","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Eklira","Tudorza pressair"],"synonyms":["14115700","Aclidinium bromide","Genuair","LAS 34273","LAS 34273 MICRONIZED","LAS W-330","LAS-34273","LAS-34273 MICRONIZED","LAS-W-330"],"crossReferences":{"DailyMed":["aclidinium%20bromide"],"Wikipedia":["Aclidinium_bromide"],"chEBI":["65344"]},"linkedTargets":{"rows":["ENSG00000133019"],"count":1},"linkedDiseases":{"rows":["HP_0006536","EFO_0000464","EFO_0006505","MONDO_0004979","EFO_0003768","EFO_0000341"],"count":6},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2012 and has 5 approved and 1 investigational indication."}
{"id":"CHEMBL564085","canonicalSmiles":"CO[C@H]1C[C@H](O[C@@H]2[C@@H](C)C(=O)O[C@H](C)[C@H](C)[C@H](OC(C)=O)[C@@H](C)C(=O)[C@]3(CO3)C[C@H](C)[C@H](O[C@@H]3O[C@H](C)C[C@H](N(C)C)[C@H]3OC(C)=O)[C@H]2C)O[C@@H](C)[C@@H]1OC(C)=O","inchiKey":"LQCLVBQBTUVCEQ-QTFUVMRISA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TROLEANDOMYCIN","yearOfFirstApproval":1969,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Acetyloleandomycin","NSC-108166","Oleandomycin (as troleandomycin)","Oleandomycin triacetate ester","Triacetyloleandomycin","Troleandomycin"],"crossReferences":{"Wikipedia":["Troleandomycin"],"drugbank":["DB13179"],"chEBI":["45735"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1969 and is indicated for bacterial disease and has 1 investigational indication."}
{"id":"CHEMBL568150","canonicalSmiles":"O=C1NC(=O)/C(=C/c2ccc3nccnc3c2)S1","inchiKey":"SQWZFLMPDUSYGV-POHAHGRESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AS-605240","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AS-605240"],"crossReferences":{"PubChem":["90341202"],"drugbank":["DB04769"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL58711","canonicalSmiles":"CC(C)=CCN1Cc2c(Cl)ccc3[nH]c(=S)n(c23)C[C@@H]1C","inchiKey":"ZNFFMCYSMBXZQU-NSHDSACASA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TIVIRAPINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["NSC-636661","R-87027","Tivirapine"],"crossReferences":{"drugbank":["DB08600"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL63","canonicalSmiles":"COc1ccc(C2CNC(=O)C2)cc1OC1CCCC1","inchiKey":"HJORMJIFDVBMOB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ROLIPRAM","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["(r,s)-rolipram","NSC-760125","Rolipram","SB-95952","ZK 62 711","ZK-62711","ZK-62771"],"crossReferences":{"PubChem":["144204223","170465962","26719663","26719664","26752319","26752320","50105263","56422401","85231212","855869","90341367"],"Wikipedia":["Rolipram"],"drugbank":["DB01954"],"chEBI":["104872"]},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL83668","canonicalSmiles":"Cc1cccc(N(C)C(=S)Oc2ccc3ccccc3c2)c1","inchiKey":"FUSNMLFNXJSCDI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TOLNAFTATE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Aftate","Dr. scholl's athlete's foot spray","Mycil","Timoped","Tinactin","Tinaderm","Tinaderm plus","Tineafax","Tritin"],"synonyms":["NSC-233648","SCH 10144","SCH-10144","Separin","Tolnaftate"],"crossReferences":{"PubChem":["11112516","124882425","144204072","144211680","170465508","174007421","26747038","56422400","855906"],"Wikipedia":["Tolnaftate"],"drugbank":["DB00525"],"chEBI":["9620"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and has 4 approved and 1 investigational indication."}
{"id":"CHEMBL9194","canonicalSmiles":"CCCCN(CCCC)C(=O)CN1C[C@H](c2ccc3c(c2)OCO3)[C@@H](C(=O)O)[C@@H]1c1ccc(OC)cc1","inchiKey":"MOTJMGVDPWRKOC-QPVYNBJUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ATRASENTAN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["A-127722","Atrasentan"],"crossReferences":{"Wikipedia":["Atrasentan"],"drugbank":["DB06199"]},"childChemblIds":["CHEMBL2106068"],"linkedTargets":{"rows":["ENSG00000151617"],"count":1},"linkedDiseases":{"rows":["MONDO_0002158","EFO_0000401","MONDO_0008170","EFO_0000673","MONDO_0002367","EFO_1001461","EFO_0004194","MONDO_0002087","MONDO_0024880","MONDO_0008315","EFO_1000158"],"count":11},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 9 investigational indications."}
{"id":"CHEMBL932","canonicalSmiles":"OCCN(CCO)c1nc(N2CCCCC2)c2nc(N(CCO)CCO)nc(N3CCCCC3)c2n1","inchiKey":"IZEKFCXSFNUWAM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DIPYRIDAMOLE","yearOfFirstApproval":1961,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Attia","Cerebrovase 100","Cerebrovase 25","Dipyridamole","Iv persantine","Modaplate","Ofcram pr","Persantin","Persantin ret","Persantine","Pyridantin","Vasyrol"],"synonyms":["B01AC07","Dipyridamole","NSC-515776","RA-8"],"crossReferences":{"DailyMed":["dipyridamole"],"PubChem":["104171148","11111116","11111117","11113358","124879978","124879980","124879984","144203684","170464694","26747068","26751580","26751581","489152","50104213","50104215","56423153","85231021","855977","90340971"],"Wikipedia":["Dipyridamole"],"drugbank":["DB00975"],"chEBI":["4653"]},"linkedTargets":{"rows":["ENSG00000185527","ENSG00000139053","ENSG00000152270","ENSG00000112759","ENSG00000105650","ENSG00000160191","ENSG00000112541","ENSG00000132915","ENSG00000172572","ENSG00000154678","ENSG00000123360","ENSG00000171408","ENSG00000205268","ENSG00000115252","ENSG00000073417","ENSG00000133256","ENSG00000065989","ENSG00000095464","ENSG00000113448","ENSG00000186642","ENSG00000113231","ENSG00000138735","ENSG00000156973","ENSG00000184588"],"count":24},"linkedDiseases":{"rows":["EFO_0002618","EFO_0000685","EFO_0003777","Orphanet_232","EFO_1000965","EFO_0002687","EFO_0001645","MONDO_0008170","EFO_0002615","EFO_0000537","EFO_0003913","EFO_0600064","EFO_0000289","MONDO_0100096","EFO_1001375","EFO_1002000","EFO_0000712","EFO_0000764","HP_0004419","EFO_0000400","EFO_1000059"],"count":21},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1961 and has 3 approved and 13 investigational indications."}
{"id":"CHEMBL954","canonicalSmiles":"CCN(CC)CCOc1ccc(/C(=C(/Cl)c2ccccc2)c2ccccc2)cc1","inchiKey":"GKIRPKYJQBWNGO-OCEACIFDSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ENCLOMIPHENE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Cisclomiphene","Clomiphene trans-form","Enclomifene","Enclomiphene","ICI-46476","ISOMER B","ISOMER-B","Isomer B","Milophene","RMI 16,289","RMI-16289","Rmi-16,289","Serophene"],"crossReferences":{"PubChem":["50085975"],"drugbank":["DB06735"]},"childChemblIds":["CHEMBL1200667"],"linkedTargets":{"rows":["ENSG00000091831"],"count":1},"linkedDiseases":{"rows":["MONDO_0002146","EFO_0000545","EFO_0001073","EFO_0000660","MONDO_0018555"],"count":5},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 6 investigational indications."}
